Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating Temozolomide in combination with radiation therapy and Tumor Treating Fields Therapy for glioblastoma has completed; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)
  • Tumor Treating Fields therapy (tumor treating fields)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Glioblastoma | EARLY_Phase 1 | Status: COMPLETED